Advertisement

Solventum Corporation SOLV

Set alert

Price alert · SOLV

All alert types
81.33 USD -2.23 -2.67%

At close · Oct 30

81.33 0.00 0.00%

After hours · Oct 30, 4:02 PM ET

Bid
81.28 × 200
Ask
81.34 × 200
80.76 Day range 84.48
62.49 52-week range 92.44
YTD
+2.64%
1 year
+17.39%
Open
84.15
Prev close
83.56
Mkt cap
13.84B
Vol
1.07M
Avg vol
1.04M
EPS
8.17
P/E
9.95
Div yield
0.00%
More statistics
Low
80.76
High
84.48
Forward P/E
11.19
Beta
0.70
Short ratio
5.04
Inst. own
75.94%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
88.24
200-d avg
78.36
1y target
94.69

MAX chart

Chart tools
Interval
SOLV all-time price chart47.259.471.683.896.0Mar 24Sep 24Apr 25Oct 25Apr 26Oct 26

Key statistics

Market cap
13.84B
Enterprise value
19.12B
Trailing P/E
9.95
Forward P/E
11.19
PEG ratio
1.22
Price / sales
1.67
Price / book
2.88
EPS (TTM)
8.17
Beta
0.70
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
17.26%
Revenue (TTM)
8.31B
Revenue growth
2.20%
Free cash flow
489.00M
Total cash
403.00M
Total debt
5.30B
Return on equity
33.96%
Shares outstanding
170.22M
Short % of float
3.43%
50-day average
88.24
200-day average
78.36

Analyst view

Consensus: buy

Buy
Price target (mean) 94.69 +16.4% upside
Target (low)
71.00
Target (mean)
94.69
Target (high)
113.00
Ratings (0m) 15 8 buy · 5 hold · 2 sell
  • Strong buy1
  • Buy7
  • Hold5
  • Sell1
  • Strong sell1

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 1.34.

Earnings history

Financials — quick view

All financials
SOLV Revenue — quarterly 2.21B
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SOLV Net income — quarterly 92.00M
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SOLV EPS — quarterly 0.53
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SOLV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20261.34———
Aug 5, 2026Jun 30, 20261.902.55+0.65+34.21%
May 5, 2026Mar 31, 20261.351.48+0.13+9.63%
Feb 26, 2026Dec 31, 20251.501.57+0.07+4.67%
Nov 6, 2025Sep 30, 20251.431.50+0.07+4.90%
Aug 7, 2025Jun 30, 20251.451.69+0.24+16.55%

Upgrades / downgrades

SOLV analyst upgrades and downgrades
DateFirmActionFromTo
Sep 14, 2026BTIGreitBuyBuy
Aug 6, 2026UBSmainBuyBuy
Aug 6, 2026Piper SandlermainOverweightOverweight
Aug 6, 2026WedbushmainOutperformOutperform
Aug 6, 2026KeybancmainOverweightOverweight
Aug 6, 2026StifelmainBuyBuy

About Solventum Corporation

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on SOLV — it syncs with the Stock Master app.

Insider holders

SOLV insider holders
InsiderRelationLatest transactionDateShares held
3M COBeneficial Owner of more than 10% of a Class of SecuritySaleAug 14, 202525,569,200
COX CARRIE SMITHDirectorConversion of Exercise of derivative securityApr 29, 202616,400
GOMEZ TAMMY LOfficerConversion of Exercise of derivative securityMay 12, 202613,362
HANSON BRYAN CRAIGChief Executive OfficerConversion of Exercise of derivative securityAug 31, 2026185,515
HARRINGTON PAUL SOfficerConversion of Exercise of derivative securityMay 12, 202620,452
KIRBERGER MARCELA A.OfficerConversion of Exercise of derivative securityMay 12, 202613,540

Institution ownership

SOLV institution ownership
Holder% heldSharesValueReported
Independent Franchise Partners, LLP9.50%16,170,0381.31BJun 29, 2026
Blackrock Inc.5.73%9,761,863793.74MJun 29, 2026
Vanguard Capital Management LLC5.65%9,624,829782.59MJun 29, 2026
Trian Fund Management, LP4.84%8,236,753669.73MJun 29, 2026
Vanguard Portfolio Management LLC3.72%6,328,641514.58MJun 29, 2026
Davis Selected Advisers3.71%6,307,729512.88MJun 29, 2026

Fund ownership

SOLV fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.75%4,674,934380.12MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.24%3,816,022310.28MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.98%3,375,087274.43MJun 29, 2026
John Hancock Funds III-Disciplined Value Mid Cap Fund1.40%2,385,590193.97MAug 30, 2026
Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF1.28%2,172,808176.67MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund1.26%2,138,463173.88MJun 29, 2026
Advertisement